Showing results (361-370 of 790) with videos related to

Sort By:
Pageof 79
Gynecologic Oncology Reports|February 22, 2020
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)Elizabeth K Lee, Zhenying Tan-Wasielewski, Carol Aghajanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2011
A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistanceTodd W Miller, Justin M Balko, Zara Ghazoui, et al.
Oncotarget|September 17, 2017
Genomic analysis of exceptional responder to regorafenib in treatment-refractory metastatic rectal cancer: a case report and review of the literatureKrittiya Korphaisarn, Jonathan M Loree, Van Nguyen, et al.
The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.
JAMA Oncology|July 17, 2015
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian CarcinomaYuexin Liu, Maya Yasukawa, Kexin Chen, et al.
Chemmedchem|August 8, 2006
Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonistsLian Qian, Yong Xu, Ted Simper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2Robert J G Cardnell, Carmen Behrens, Lixia Diao, et al.
Oncotarget|July 1, 2014
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerShuying Liu, Xiaolong Meng, Huiqin Chen, et al.
Molecular Cancer Therapeutics|September 30, 2010
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancerDavid Luyimbazi, Argun Akcakanat, Priscilla F McAuliffe, et al.
Molecular Cancer Therapeutics|August 15, 2014
Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4DNingning He, Nayoung Kim, Mee Song, et al.
Pageof 79